We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.96T Turnover 11.55%
1-Year Est. Return 27.49%
 

Morgan Stanley is a financial services company with divisions for institutional services, wealth management and investment management. Its institutional arm advises large institutions on strategy and raising capital, its wealth arm serves individuals and family offices and runs the E-Trade self-directed investing service, and its investment arm offers hedge fund, real estate and infrastructure strategies as well as private equity and private credit. It was founded in 1935 by Harold Stanley and Henry Sturgis Morgan, who was J.P. Morgan's grandson, both leaving J.P. Morgan & Co., after the Glass-Steagall Act forced commercial and investment banking apart. In 1997 it merged with Dean Witter Discover, the financial services business Sears had spun off, and it went back to the Morgan Stanley name in 2001. In 2009 its wealth business was merged with Citigroup's Smith Barney, and in 2012 Morgan Stanley bought a larger share of that venture from Citigroup. Morgan Stanley later bought E-Trade in 2020 and Eaton Vance in 2021.

This Fund
S&P 500
This Quarter Est. Return
+2.8%
1 Year Est. Return
+27.49%
3 Year Est. Return
+120.22%
5 Year Est. Return
+126.21%
10 Year Est. Return
+484.42%
AUM
$1.96T
AUM Growth
+$65.1B
Cap. Flow
+$52B
Cap. Flow %
2.66%
Top 10 Hldgs %
23%
Holding
8,655
New
249
Increased
3,922
Reduced
2,977
Closed
751
Avg Time Held
7.8 years
Top 10 Avg Time Held
6.9 years
Top 20 Avg Time Held
5.9 years

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$2.16B
2
MCK icon
McKesson
MCK
+$1.28B
3
AON icon
Aon
AON
+$1.02B
4
NET icon
Cloudflare
NET
+$1.01B
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$863M

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.46%
2 Technology 25.56%
3 Financials 9.5%
4 Healthcare 7.37%
5 Communication Services 6.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TRDA icon
4676
Entrada Therapeutics
TRDA
$196M
$2.45M ﹤0.01%
386,243
+194,593
+102% +$1.35M
2021 Q4
19 quarters
MHF icon
4677
Western Asset Municipal High Income Fund
MHF
$138M
$2.45M ﹤0.01%
408,075
-2,890
-0.7% -$19.5K
2013 Q2
53 quarters
AMRN icon
4678
Amarin
AMRN
$475M
$2.45M ﹤0.01%
188,616
-35,001
-16% -$494K
2013 Q2
53 quarters
EMF icon
4679
Templeton Emerging Markets Fund
EMF
$290M
$2.45M ﹤0.01%
110,011
+8,543
+8% +$189K
2013 Q2
53 quarters
CDZI icon
4680
Cadiz
CDZI
$273M
$2.45M ﹤0.01%
624,302
-380,847
-38% -$1.39M
2013 Q2
53 quarters
SPFF icon
4681
Global X SuperIncome Preferred ETF
SPFF
$129M
$2.45M ﹤0.01%
269,589
+26,812
+11% +$251K
2013 Q2
53 quarters
ALT icon
4682
Altimmune
ALT
$298M
$2.43M ﹤0.01%
850,208
+91,773
+12% +$282K
2019 Q2
29 quarters
GCV icon
4683
Gabelli Convertible and Income Securities Fund
GCV
$74.7M
$2.43M ﹤0.01%
586,877
-28,323
-5% -$129K
2013 Q2
53 quarters
HPF icon
4684
John Hancock Preferred Income Fund II
HPF
$271M
$2.42M ﹤0.01%
179,732
+4,406
+3% +$67.8K
2013 Q2
53 quarters
RAAR icon
4685
Reckoner Yield Enhanced AAA CLO Reinvesting ETF
RAAR
$13M
$2.42M ﹤0.01%
46,957
– –
2026 Q1
2 quarters
PAYH icon
4686
TrueShares S&P Autocallable High Income ETF
PAYH
$24.6M
$2.42M ﹤0.01%
96,996
-32,745
-25% -$818K
2026 Q1
2 quarters
FUND icon
4687
Sprott Focus Trust
FUND
$290M
$2.42M ﹤0.01%
249,379
+491
+0.2% +$5K
2013 Q2
53 quarters
JBIO icon
4688
Jade Biosciences
JBIO
$1.06B
$2.42M ﹤0.01%
171,969
+47,456
+38% +$952K
2021 Q3
20 quarters
SI icon
4689
Shoulder Innovations
SI
$428M
$2.42M ﹤0.01%
127,810
+10,545
+9% +$217K
2025 Q3
4 quarters
PDT icon
4690
John Hancock Premium Dividend Fund
PDT
$582M
$2.41M ﹤0.01%
205,797
-44,163
-18% -$556K
2013 Q2
53 quarters
KRUS icon
4691
Kura Sushi USA
KRUS
$301M
$2.41M ﹤0.01%
59,034
+21,178
+56% +$976K
2019 Q3
28 quarters
VGI icon
4692
Virtus Global Multi-Sector Income Fund
VGI
$75M
$2.41M ﹤0.01%
356,499
+35,333
+11% +$256K
2013 Q2
53 quarters
ALIT icon
4693
Alight
ALIT
$330M
$2.4M ﹤0.01%
269,456
+204,478
+315% +$3.14M
2021 Q3
20 quarters
QTRX icon
4694
Quanterix
QTRX
$135M
$2.4M ﹤0.01%
646,017
+198,329
+44% +$653K
2017 Q4
35 quarters
CERS icon
4695
Cerus
CERS
$376M
$2.4M ﹤0.01%
1,006,877
-111,385
-10% -$306K
2013 Q2
53 quarters
IIIV icon
4696
i3 Verticals
IIIV
$337M
$2.38M ﹤0.01%
172,336
+108,587
+170% +$1.95M
2018 Q2
33 quarters
BCYC icon
4697
Bicycle Therapeutics
BCYC
$223M
$2.36M ﹤0.01%
640,522
-26,747
-4% -$108K
2019 Q4
27 quarters
SCOP icon
4698
Sprott Physical Copper Trust
SCOP
$174M
$2.35M ﹤0.01%
193,156
+10,732
+6% +$124K
2026 Q2
1 quarter
INFL icon
4699
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.5B
$2.35M ﹤0.01%
46,803
+6,138
+15% +$322K
2021 Q2
21 quarters
FF icon
4700
Future Fuel
FF
$136M
$2.35M ﹤0.01%
459,089
+154,423
+51% +$795K
2013 Q2
53 quarters

Similar funds

Morgan Stanley's Q3 2026 Portfolio in Review

As of Q3 2026, Morgan Stanley held 8,655 positions worth $1.96T, up 3.4% from $1.89T the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Morgan Stanley's Q3 2026 filing shows 249 new, 3,922 increased, 2,977 reduced and 751 closed positions. Its largest new stake was SK Hynix: 10,652,586 shares worth $1.96B. The largest sale was Salesforce, an estimated $2.16B.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q3 2026 buy was SK Hynix: 10,652,586 shares worth $1.96B.
  • Morgan Stanley added most to Western Midstream Partners in Q3 2026, an estimated $9.7B increase.
  • Morgan Stanley's biggest Q3 2026 reduction was Salesforce, cutting an estimated $2.16B.
  • Morgan Stanley fully exited Electronic Arts in Q3 2026, selling an estimated $623M.
  • Morgan Stanley's ten largest holdings make up 23% of its $1.96T portfolio in Q3 2026.
  • Morgan Stanley opened 249 new positions and closed 751 in Q3 2026.
  • Morgan Stanley's portfolio value rose 3.4% quarter-over-quarter to $1.96T.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.